3.42Open3.50Pre Close3 Volume4 Open Interest15.00Strike Price982.00Turnover0.00%IV1.85%PremiumDec 20, 2024Expiry Date2.87Intrinsic Value100Multiplier-1DDays to Expiry0.33Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma5.33Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet